- Drug Pipelines
- June 2020
- 4664 Pages
From €2174EUR$2,500USD£1,935GBP
- Drug Pipelines
- June 2020
- 1397 Pages
From €1740EUR$2,000USD£1,548GBP
- Report
- June 2020
- 204 Pages
From €2700EUR$3,104USD£2,402GBP
€3000EUR$3,449USD£2,669GBP
- Report
- June 2020
- 231 Pages
From €2700EUR$3,104USD£2,402GBP
€3000EUR$3,449USD£2,669GBP
- Report
- June 2020
- 204 Pages
From €2700EUR$3,104USD£2,402GBP
€3000EUR$3,449USD£2,669GBP
From €948EUR$1,090USD£843GBP
From €1035EUR$1,190USD£921GBP
From €948EUR$1,090USD£843GBP
From €3470EUR$3,990USD£3,087GBP
- Drug Pipelines
- February 2020
- 106 Pages
From €1740EUR$2,000USD£1,548GBP
- Drug Pipelines
- February 2020
- 106 Pages
From €1305EUR$1,500USD£1,161GBP
- Report
- February 2020
- 120 Pages
From €3697EUR$4,250USD£3,289GBP
From €4671EUR$5,370USD£4,155GBP
From €4671EUR$5,370USD£4,155GBP
- Report
- July 2020
- 90 Pages
From €743EUR$854USD£661GBP
€825EUR$949USD£734GBP
- Report
- July 2020
- 88 Pages
From €743EUR$854USD£661GBP
€825EUR$949USD£734GBP
- Report
- July 2020
- 99 Pages
From €743EUR$854USD£661GBP
€825EUR$949USD£734GBP
From €1540EUR$1,770USD£1,370GBP
From €1540EUR$1,770USD£1,370GBP
From €1540EUR$1,770USD£1,370GBP

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more